Literature DB >> 31911233

Early immune stimulation and childhood acute lymphoblastic leukemia in Costa Rica: A comparison of statistical approaches.

Sophia Colombari Figueroa1, Chris J Kennedy2, Catharina Wesseling3, Joseph M Wiemels4, Libby Morimoto2, Ana M Mora5.   

Abstract

BACKGROUND: Although epidemiologic studies suggest that early immune stimulation is protective against childhood leukemia, evidence for this relationship is equivocal for Hispanic children, who are disproportionately affected by this disease. The complex biological processes underlying immune stimulation and leukemogenesis may benefit from novel statistical approaches that account for mixed exposures and their nonlinear interactions. In this study, we utilized targeted machine learning and traditional statistical methods to investigate the association of multiple measures of early immune stimulation with acute lymphoblastic leukemia (ALL) in Costa Rican children.
MATERIALS AND METHODS: We used data from a population-based case-control study conducted in Costa Rica (2001-2003). Cases of ALL (n = 240) were diagnosed in 1995-2000 (age >1 year and <15 years at diagnosis) and were identified through the National Cancer Registry and National Children's Hospital. Population controls (n = 578) were frequency-matched to cases by birth year and drawn from the National Birth Registry. Data on surrogate measures of early immune stimulation were collected through in-home interviews. We fitted multivariable models, utilizing targeted causal inference (varimpact), unconditional logistic regression, and latent class analysis (LCA).
RESULTS: In varimpact analysis, contact with any pet [risk difference (RD) = -0.17, 95% CI: -0.25, -0.10)] or any farm animal (RD = -0.07, 95% CI: -0.13, 0.00) and allergies (RD = -0.08, 95% CI: -0.17, 0.01) were associated with a reduced risk of ALL, whereas experiencing a fever longer than one week was associated with an increased risk (RD = 0.23, 95% CI: 0.12, 0.33). In unconditional logistic regression models, contact with any pet or farm animal and a complete vaccination scheme were inversely associated with odds of ALL (OR = 0.44, 95% CI: 0.31, 0.62; OR = 0.66, 95% CI: 0.49, 0.90; OR = 0.45, 95% CI: 0.24, 0.83; respectively), whereas experiencing a fever longer than one week was positively associated with ALL (OR = 2.44, 95% CI: 1.61, 3.70). Two-class and three-class LCA revealed a group with elevated risk for ALL whose exposure profile was mainly characterized by reduced exposure to pets and farm animals.
CONCLUSIONS: Using distinct statistical approaches, we observed that exposure to pets and farm animals was inversely associated with ALL risk, whereas having a fever longer than one week (a putative proxy of severe infection) was associated with an increased risk. For multifactorial diseases such as childhood leukemia, we recommend estimating the joint effects of multiple exposures by applying diverse statistical methods and interpreting their results together. Overall, we found support for the hypothesis that early immune stimulation offers protection against childhood ALL.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Childhood cancer; Costa Rica; Early immune stimulation; Hispanic children; Machine learning

Mesh:

Year:  2019        PMID: 31911233      PMCID: PMC7605596          DOI: 10.1016/j.envres.2019.109023

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  38 in total

1.  Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study.

Authors:  Jérémie Rudant; Tracy Lightfoot; Kevin Y Urayama; Eleni Petridou; John D Dockerty; Corrado Magnani; Elizabeth Milne; Logan G Spector; Lesley J Ashton; Nikolaos Dessypris; Alice Y Kang; Margaret Miller; Roberto Rondelli; Jill Simpson; Eftichia Stiakaki; Laurent Orsi; Eve Roman; Catherine Metayer; Claire Infante-Rivard; Jacqueline Clavel
Journal:  Am J Epidemiol       Date:  2015-03-01       Impact factor: 4.897

Review 2.  Speculations on the cause of childhood acute lymphoblastic leukemia.

Authors:  M F Greaves
Journal:  Leukemia       Date:  1988-02       Impact factor: 11.528

3.  Vaccination history and risk of childhood leukaemia.

Authors:  Xiaomei Ma; Monique B Does; Catherine Metayer; Carolyn Russo; Alan Wong; Patricia A Buffler
Journal:  Int J Epidemiol       Date:  2005-06-10       Impact factor: 7.196

4.  Childhood and adolescent cancer statistics, 2014.

Authors:  Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-31       Impact factor: 508.702

5.  Childhood acute leukemia, early common infections, and allergy: The ESCALE Study.

Authors:  Jérémie Rudant; Laurent Orsi; Florence Menegaux; Arnaud Petit; André Baruchel; Yves Bertrand; Anne Lambilliotte; Alain Robert; Gérard Michel; Geneviève Margueritte; Julie Tandonnet; Françoise Mechinaud; Pierre Bordigoni; Denis Hémon; Jacqueline Clavel
Journal:  Am J Epidemiol       Date:  2010-08-31       Impact factor: 4.897

6.  Allergy and risk of childhood leukaemia: results from the UKCCS.

Authors:  Ann M Hughes; Tracy Lightfoot; Jill Simpson; Pat Ansell; Patricia A McKinney; Sally E Kinsey; Christopher D Mitchell; Tim O B Eden; Mel Greaves; Eve Roman
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

7.  Medically diagnosed infections and risk of childhood leukaemia: a population-based case-control study.

Authors:  Jeffrey S Chang; Chia-Rung Tsai; Yi-Wen Tsai; Joseph L Wiemels
Journal:  Int J Epidemiol       Date:  2012-07-26       Impact factor: 7.196

8.  Epidemiological evidence for an infective basis in childhood leukaemia.

Authors:  L J Kinlen
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

9.  International incidence of childhood cancer, 2001-10: a population-based registry study.

Authors:  Eva Steliarova-Foucher; Murielle Colombet; Lynn A G Ries; Florencia Moreno; Anastasia Dolya; Freddie Bray; Peter Hesseling; Hee Young Shin; Charles A Stiller
Journal:  Lancet Oncol       Date:  2017-04-11       Impact factor: 41.316

10.  Respiratory mortality of childhood, adolescent and young adult cancer survivors.

Authors:  Miranda M Fidler; Raoul C Reulen; Chloe J Bright; Katherine E Henson; Julie S Kelly; Meriel Jenney; Antony Ng; Jeremy Whelan; David L Winter; Clare Frobisher; Michael M Hawkins
Journal:  Thorax       Date:  2018-05-10       Impact factor: 9.139

View more
  4 in total

1.  Identification of high-risk and low-risk clusters and estimation of the relative risk of acute lymphoblastic leukemia in provinces of Iran during 2006-2014 period: A geo-epidemiological study.

Authors:  Sajjad Rahimi Pordanjani; Amir Kavousi; Babak Mirbagheri; Abbas Shahsavani; Koorosh Etemad
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

2.  Vaccination and the Risk of Childhood Cancer-A Systematic Review and Meta-Analysis.

Authors:  Manuela Marron; Lara Kim Brackmann; Pia Kuhse; Lara Christianson; Ingo Langner; Ulrike Haug; Wolfgang Ahrens
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

3.  Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia Group.

Authors:  Kun-Yin Qiu; Hong-Gui Xu; Xue-Qun Luo; Hui-Rong Mai; Ning Liao; Li-Hua Yang; Min-Cui Zheng; Wu-Qing Wan; Xue-Dong Wu; Ri-Yang Liu; Qi-Wen Chen; Hui-Qin Chen; Xiao-Fei Sun; Hua Jiang; Xing-Jiang Long; Guo-Hua Chen; Xin-Yu Li; Chang-Gang Li; Li-Bin Huang; Ya-Yun Ling; Dan-Na Lin; Chuan Wen; Wen-Yong Kuang; Xiao-Qin Feng; Zhong-Lv Ye; Bei-Yan Wu; Xiang-Lin He; Qiao-Ru Li; Li-Na Wang; Xian-Ling Kong; Lu-Hong Xu; Chi-Kong Li; Jian-Pei Fang
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

4.  An Expanded Obstetric Comorbidity Scoring System for Predicting Severe Maternal Morbidity.

Authors:  Stephanie A Leonard; Chris J Kennedy; Suzan L Carmichael; Deirdre J Lyell; Elliott K Main
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.